In Utero Transplantation

Thomas' Hematopoietic Cell Transplantation: Stem Cell Transplantation, Fourth Edition

Volumn , Issue , 2009, Pages 577-589

  Flake, Alan W ^a,b   Zanjani, Esmail D ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^c UNIVERSITY OF NEVADA   (United States)

Author keywords

Clinical experience with IU HCT; Diseases with selective advantage for normal cells; Donor cell source; Fetal hematopoietic environment; Fetal immunologic tolerance; In utero transplantation; IU HCT currently in its early stages of development; Maternal and fetal risk; Strategies for successful in utero HSC transplantation

Indexed keywords

EID: 84890702658     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444303537.ch40     Document Type: Chapter

References (124)

1. Harrison MR. Fetal surgery. West J Med 1990; 153: 648.
2. Moise KJ, Jr. Intrauterine transfusion with red cells and platelets. West J Med 1993; 159: 318-24.
3. Kitano Y, Flake AW, Crombleholme TM, Johnson MP, Adzick NS. Open fetal surgery for life-threatening fetal malformations. Semin Perinatol 1999; 23: 448-61.
4. Owen RD. Immunogenetic consequences of vascular anastomoses between bovine cattle twins. Science 1945; 102: 400-1.
5. Anderson D, Billingham R, Lampkin G, Medawar P. The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity 1951; 5: 379-97.
6. Simonsen M. The acquired immunity concept in kidney homotransplantation. Ann N Y Acad Sci 1955; 59: 448-52.
7. Picus J, Aldrich WR, Letvin NL. A naturally occurring bone-marrow-chimeric primate. I. Integrity of its immune system. Transplantation 1985; 39: 297-303.
8. van Dijk B, Bommsma D, de Man A. Blood group chimerism in human multiple births is not rare. Am J Med Genet 1996; 61: 264-8.
9. Gill T. Chimerism in humans. Transplant Proc 1977; 9: 1423-31.
10. Burnet M. The clonal selection theory of acquired immunity. London: Cambridge University Press; 1959.
11. Billingham R, Brent L, Medawar PB. Actively acquired tolerance of foreign cells. Nature 1953; 172: 603-7.
12. Sprent J. Central tolerance of T cells. Int Rev Immunol 1995; 13: 95-105.
13. Anderson G, Moore NC, Owen JJ, Jenkinson EJ. Cellular interactions in thymocyte development. Annu Rev Immunol 1996; 14: 73-99.
14. Haynes BF, Martin ME, Kay HH, Kurtzberg J. Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues. J Exp Med 1988; 168: 1061-80.
15. Blackburn CC, Manley NR. Developing a new paradigm for thymus organogenesis. Nat Rev Immunol 2004; 4: 278-89.
16. Strominger JL. Developmental biology of T cell receptors. Science 1989; 244: 943-50.
17. Sandberg JK, Franksson L, Sundback J et al. T cell tolerance based on avidity thresholds rather than complete deletion allows maintenance of maximal repertoire diversity. J Immunol 2000; 165: 25-33.
18. Wells AD, Li XC, Strom TB, Turka LA. The role of peripheral T-cell deletion in transplantation tolerance. Philos Trans R Soc Lond B Biol Sci 2001; 356: 617-23.
19. Yan J, Mamula MJ. Autoreactive T cells revealed in the normal repertoire: escape from negative selection and peripheral tolerance. J Immunol 2002; 168: 3188-94.
20. Yui K, Komori S, Katsumata M, Siegel RM, Greene MI. Self-reactive T cells can escape clonal deletion in T-cell receptor V beta 8.1 transgenic mice. Proc Natl Acad Sci U S A 1990; 87: 7135-9.
21. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995; 155: 1151-64.
22. Takahashi T, Tagami T, Yamazaki S et al. Immunologic self-tolerance maintained by CD25(+) CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000; 192: 303-10.
23. Hayashi S, Peranteau WH, Shaaban AF, Flake AW. Complete allogeneic hematopoietic chimerism achieved by a combined strategy of in utero hematopoietic stem cell transplantation and postnatal donor lymphocyte infusion. Blood 2002; 100: 804-12.
24. Kim HB, Shaaban AF, Milner R, Fichter C, Flake AW. In utero bone marrow transplantation induces tolerance by a combination of clonal deletion and anergy. J Pediatr Surg 1999; 34: 726-30.
25. Peranteau WH, Endo M, Adibe OO, Flake AW. Evidence for an immune barrier after in utero hematopoietic-cell transplantation. Blood 2007; 109: 1331-3.
26. Barker JE, Schuldt AJ, Lessard MD, Jude CD, Vogler CA, Soper BW. Donor cell replacement in mice transplanted in utero is limited by immuneindependent mechanisms. Blood Cells Mol Dis 2003; 31: 291-7.
27. Carrier E, Gilpin E, Lee TH, Busch MP, Zanetti M. Microchimerism does not induce tolerance after in utero transplantation and may lead to the development of alloreactivity. J Lab Clin Med 2000; 136: 224-35.
28. Metcalf D, Moore MAS. Embryonic aspects of haemopoiesis. In: Neuberger A, Tatum EL, editors. Haemopoietic Cells. Vol. 24. Amsterdam: North-Holland Publishing; 1971. Chapter 4.
29. Tavian M, Coulombel L, Luton D, San Clemente H, Dieterlen-Lievre F, Peault B. Aorta-associated CD34+ hematopoietic cells in the early human embryo. Blood 1996; 87: 67-72.
30. Badillo AT, Flake AW. The regulatory role of the stromal microenvironment in fetal hematopoietic ontogeny. Stem Cell Rev 2007; 2: 241-6.
31. Zanjani ED, Ascensao JL, Tavassoli M. Liverderived fetal hematopoietic stem cells selectively and preferentially home to the fetal bone marrow. Blood 1993; 81: 399-404.
32. Shaaban AF, Kim HB, Milner R, Flake AW. A kinetic model for homing and migration of prenatally transplanted marrow. Blood 1999; 94: 3251-7.
33. Peranteau WH, Endo M, Adibe OO, Merchant A, Zoltick PW, Flake AW. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood 2006; 108: 4268-74.
34. Flake AW, Harrison MR, Adzick NS, Zanjani ED. Transplantation of fetal hematopoietic stem cells in utero: the creation of hematopoietic chimeras. Science 1986; 233: 776-8.
35. Zanjani ED, Ascensao JL, Flake AW, Harrison MR, Tavassoli M. The fetus as an optimal donor and recipient of hemopoietic stem cells. Bone Marrow Transplant 1992; 10(Suppl 1): 107-14.
36. Flake A, Zanjani E. Cellular therapy. New trends and controversies in fetal diagnosis and therapy. Obstet Gynecol Clin N Am 1997; 24: 159-77.
37. Javazon EH, Merchant AM, Danzer E, Flake AW. Reconstitution of hematopoiesis following intrauterine transplantation of stem cells. Methods Mol Med 2005; 105: 81-94.
38. Harrison MR, Slotnick RN, Crombleholme TM, Golbus MS, Tarantal AF, Zanjani ED. In-utero transplantation of fetal liver haemopoietic stem cells in monkeys. Lancet 1989; 2: 1425-7.
39. Shields LE, Bryant EM, Easterling TR, Andrews RG. Fetal liver cell transplantation for the creation of lymphohematopoietic chimerism in fetal baboons. Am J Obstet Gynecol 1995; 173: 1157-60.
40. Shields LE, Gaur L, Delio P et al. The use of CD 34(+) mobilized peripheral blood as a donor cell source does not improve chimerism after in utero hematopoietic stem cell transplantation in nonhuman primates. J Med Primatol 2005; 34: 201-8.
41. Shields LE, Gaur L, Delio P, Potter J, Sieverkropp A, Andrews RG. Fetal immune suppression as adjunctive therapy for in utero hematopoietic stem cell transplantation in nonhuman primates. Stem Cells 2004; 22: 759-69.
42. Shields LE, Gaur LK, Gough M, Potter J, Sieverkropp A, Andrews RG. In utero hematopoietic stem cell transplantation in nonhuman primates: the role of T cells. Stem Cells 2003; 21: 304-14.
43. Cowan MJ, Tarantal AF, Capper J, Harrison M, Garovoy M. Long-term engraftment following in utero T cell-depleted parental marrow transplantation into fetal rhesus monkeys. Bone Marrow Transplant 1996; 17: 1157-65.
44. Lee PW, Cina RA, Randolph MA et al. In utero bone marrow transplantation induces kidney allograft tolerance across a full major histocompatibility complex barrier in swine. Transplantation 2005; 79: 1084-90.
45. Lee PW, Cina RA, Randolph MA et al. Stable multilineage chimerism across full MHC barriers without graft-versus-host disease following in utero bone marrow transplantation in pigs. Exp Hematol 2005; 33: 371-9.
46. Lovell KL, Kraemer SA, Leipprandt JR et al. In utero hematopoietic stem cell transplantation: a caprine model for prenatal therapy in inherited metabolic diseases. Fetal Diagn Ther 2001; 16: 13-17.
47. Oppenheim SM, Muench MO, Gutierrez-Adan A et al. Hematopoietic stem cell transplantation in utero produces sheep-goat chimeras. Blood Cells Mol Dis 2001; 27: 296-308.
48. Blakemore K, Hattenburg C, Stetten G et al. In utero hematopoietic stem cell transplantation with haploidentical donor adult bone marrow in a canine model. Am J Obstet Gynecol 2004; 190: 960-73.
49. Omori F, Lutzko C, Abrams-Ogg A et al. Adoptive transfer of genetically modified human hematopoietic stem cells into preimmune canine fetuses. Exp Hematol 1999; 27: 242-9.
50. Lutzko C, Kruth S, Abrams-Ogg AC et al. Genetically corrected autologous stem cells engraft, but host immune responses limit their utility in canine alpha-L-iduronidase deficiency. Blood 1999; 93: 1895-905.
51. Petersen SM, Gendelman M, Murphy KM et al. Use of T-cell antibodies for donor dosaging in a canine model of in utero hematopoietic stem cell transplantation. Fetal Diagn Ther 2007; 22: 175-9.
52. Crombleholme TM, Harrison MR, Zanjani ED. In utero transplantation of hematopoietic stem cells in sheep: the role of T cells in engraftment and graft-versus-host disease. J Pediatr Surg 1990; 25: 885-92.
53. Fleischman R, Mintz B. Prevention of genetic anemias in mice by microinjection of normal hematopoietic cells into the fetal placenta. Proc Natl Acad Sci U S A 1979; 76: 5736-40.
54. Geissler EN, Ryan MA, Housman DE. The dominant- white spotting (W) locus of the mouse encodes the c-kit proto-oncogene. Cell 1988; 55: 185-92.
55. Mintz B, Anthony K, Litwin S. Monoclonal derivation of mouse myeloid and lymphoid lineages from totipotent hematopoietic stem cells experimentally engrafted in fetal hosts. Proc Natl Acad Sci U S A 1984; 81: 7835-9.
56. Blazar BR, Taylor PA, Vallera DA. In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities. Blood 1995; 86: 4353-66.
57. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation: ontogenic opportunities and biologic barriers. Blood 1999; 94: 2179-91.
58. Carrier E, Lee TH, Busch MP, Cowan MJ. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells. Blood 1995; 86: 4681-90.
59. Blazar BR, Taylor PA, Vallera DA. Adult bone marrow-derived pluripotent hematopoietic stem cells are engraftable when transferred in utero into moderately anemic fetal recipients. Blood 1995; 85: 833-41.
60. Kim HB, Shaaban AF, Yang EY, Liechty KW, Flake AW. Microchimerism and tolerance after in utero bone marrow transplantation in mice. J Surg Res 1998; 77: 1-5.
61. Pallavicini MG, Flake AW, Madden D et al. Hemopoietic chimerism in rodents transplanted in utero with fetal human hemopoietic cells. Transplant Proc 1992; 24: 542-3.
62. Archer DR, Turner CW, Yeager AM, Fleming WH. Sustained multilineage engraftment of allogeneic hematopoietic stem cells in NOD/SCID mice after in utero transplantation. Blood 1997; 90: 3222-9.
63. Blazer BR, Taylor PA, McElmurry R et al. Engraftment of severe combined immune defi- cient mice receiving allogeneic bone marrow via in utero or postnatal transfer. Blood 1998; 92: 3949-59.
64. Christopherson KW, 2nd, Hangoc G, Broxmeyer HE. Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1 alpha-mediated chemotaxis of human cord blood CD34+ progenitor cells. J Immunol 2002; 169: 7000-8.
65. Christopherson KW, Hangoc G, Mantel CR, Broxmeyer HE. Modulation of hematopoietic stem cell homing and engraftment by CD26. Science 2004; 305: 1000-3.
66. Peranteau WH, Endo M, Adibe OO, Merchant A, Zoltick PW, Flake AW. CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. Blood 2006; 108: 4268-74.
67. Peranteau WF, Hayashi S, Hsieh M, Shaaban AF, Flake AW. High level allogeneic chimerism achieved by prenatal tolerance induction and postnatal non-myeloablative bone marrow transplantation. Blood 2002; 100: 2225-34.
68. Ashizuka S, Peranteau WH, Hayashi S, Flake AW. Busulfan-conditioned bone marrow transplantation results in high-level allogeneic chimerism in mice made tolerant by in utero hematopoietic cell transplantation. Exp Hematol 2006; 34: 359-68.
69. Zanjani ED, Pallavicini MG, Flake AW et al. Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest 1992; 89: 1178-88.
70. Zanjani ED, Flake AW, Rice H, Hedrick M, Tavassoli M. Long-term repopulating ability of xenogeneic transplanted human fetal liver hematopoietic stem cells in sheep. J Clin Invest 1994; 93: 1051-5.
71. Shaaban AF, Milner R, Kim HB, Flake AW. High-level allogeneic hematopoietic chimerism following prenatal stem cell transplantation requires negative selection of donor thymocytes mediated by host antigen presentation cells. Exp Hematol 1999; 27(Suppl 1): 347.
72. Kim HB, Shaaban AF, Milner R, Fichter C, Flake AW. In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy. J Pediatr Surg 1999; 34: 726-9; discussion 729-30.
73. Milner R, Shaaban A, Kim HB, Fichter C, Flake AW. Postnatal booster injections increase engraftment after in utero stem cell transplantation. J Surg Res 1999; 83: 44-7.
74. Howson-Jan K, Matloub YH, Vallera DA, Blazar BR. In utero engraftment of fully H-2-incompatible versus congenic adult bone marrow transferred into nonanemic or anemic murine fetal recipients. Transplantation 1993; 56: 709-16.
75. Carrier E, Lee TH, Busch MP, Cowan MJ. Recruitment of engrafted donor cells postnatally into the blood with cytokines after in utero transplantation in mice. Transplantation 1997; 64: 627-33.
76. Almeida-Porada G, Flake AW, Glimp HA, Zanjani ED. Co-transplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cell in utero. Exp Hematol 1999; 27: 1569-75.
77. Almeida-Porada G, Porada CD, Tran N, Zanjani ED. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation. Blood 2000; 95: 3620-7.
78. Brecher G, Tjio JH, Haley JE, Narla J, Beal SL. Transplantation of murine bone marrow without prior host irradiation. Blood Cells 1979; 5: 237-46.
79. Stewart FM, Crittenden RB, Lowry PA, Pearson- White S, Quesenberry PJ. Long-term engraftment of normal and post-5-fluorouracil murine marrow into normal nonmyeloablated mice. Blood 1993; 81: 2566-71.
80. Slavin S, Nagler A, Shapira M, Panigrahi S, Samuel S, Or A. Non-myeloablative allogeneic stem cell transplantation focusing on immunotherapy of life-threatening malignant and nonmalignant diseases. Crit Rev Oncol Hematol 2001; 39: 25-9.
81. Sykes M, Preffer F, McAfee S et al. Mixed lymphohaemopoietic chimerism and graft-versuslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation [see comments]. Lancet 1999; 353: 1755-9.
82. Stewart FM, Zhong S, Wuu J, Hsieh C-C, Nilsson SK, Quesenberry PJ. Lymphohematopoietic engraftment in minimally myeloablated hosts. Blood 1998; 91: 3681-7.
83. Flake AW. Prenatal intervention: ethical considerations for life-threatening and non-life-threatening anomalies. Semin Pediatr Surg 2001; 10: 212-21.
84. Zanjani ED, Ascensao JL, Harrison MR, Tavassoli M. Ex vivo incubation with growth factors enhances the engraftment of fetal hematopoietic cells transplanted in sheep fetuses. Blood 1992; 79: 3045-9.
85. Shaaban AF, Milner R, Kim HB, Flake AW. Fetal liver is a superior donor source for the engraftment of prenatally transplanted allogeneic hematopoietic stem cells. Exp Hematol 1999; 27(Suppl 1): 121, Abstract 320.
86. Rice HE, Hedrick MH, Flake AW, Donegan E, Harrison MR. Bacterial and fungal contamination of human fetal liver collected transvaginally for hematopoietic stem cell transplantation. Fetal Diagn Ther 1993; 8: 74-8.
87. Zanjani ED, Mackintosh FR, Harrison MR. Hematopoietic chimerism in sheep and nonhuman primates by in utero transplantation of fetal hematopoietic stem cells. Blood Cells 1991; 17: 349-63.
88. Muench MO, Rae J, Barcena A et al. Transplantation of a fetus with paternal Thy-1(+)CD34(+)cells for chronic granulomatous disease. Bone Marrow Transplant 2001; 27: 355-64.
89. Hayashi S, Hsieh M, Peranteau WH, Ashizuka S, Flake AW. Complete allogeneic hematopoietic chimerism achieved by in utero hematopoietic cell transplantation and cotransplantation of LLME-treated, MHC-sensitized donor lymphocytes. Exp Hematol 2004; 32: 290-9.
90. Bhattacharyya S, Chawla A, Smith K et al. Multilineage engraftment with minimal graft-versushost disease following in utero transplantation of S-59 psoralen/ultraviolet a light-treated, sensitized T cells and adult T cell-depleted bone marrow in fetal mice. J Immunol 2002; 169: 6133-40.
91. Rhoads G, Jackson L, Schlesselman S et al. The safety and efficacy of chorionic villus sampling for early prenatal diagnosis of cytogenetic abnormalities. N Engl J Med 1989; 320: 609-17.
92. Bowman J. Hemolytic disease (erythroblastosis fetalis). In: Creasy RK, Resnik R, editors. Maternal- fetal medicine principles and practice, 3rd edn. Philadelphia: WB Saunders; 1994. pp. 730-3.
93. Mackinnon S, Papadopoulos EB, Carabasi MH et al. Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood 1995; 86: 1261-8.
94. Alain G, Carrier C, Beaumier L, Bernard J, Lemay M, Lavoie A. In utero acute graft-versus-host disease in a neonate with severe combined immuIn nodeficiency. J Am Acad Dermatol 1993; 29: 862-5.
95. Sottini A, Quiros-Roldan E, Notarangelo LD, Malagoli A, Primi D, Imberti L. Engrafted maternal T cells in a severe combined immunodeficiency patient express T-cell receptor variable beta segments characterized by a restricted V-D-J junctional diversity. Blood 1995; 85: 2105-13.
96. Flake A, Roncarolo M-G, Puck J et al. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow. N Engl J Med 1996; 335: 1806-10.
97. Wengler G, Lanfranchi A, Frusca T et al. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDX1). Lancet 1996; 348: 1484-7.
98. Pirovano S, Notarangelo LD, Malacarne F et al. Reconstitution of T-cell compartment after in utero stem cell transplantation: analysis of T-cell repertoire and thymic output. Haematologica 2004; 89: 450-61.
99. Puck JM, Deschenes SM, Porter JC et al. The interleukin-2 receptor gamma chain maps to Xq13.1 and is mutated in X-linked severe combined immunodeficiency, SCIDX1. Hum Mol Genet 1993; 2: 1099-104.
100. Buckley RH, Schiff SE, Schiff RI et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999; 340: 508-16.
101. Cavazzana-Calvo M, Hacein-Bey S, de Saint Basile G et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2000; 288: 669-72.
102. Cavazzana-Calvo M, Fischer A. Gene therapy for severe combined immunodeficiency: are we there yet? J Clin Invest 2007; 117: 1456-65.
103. Gallego MD, Santamaría M, Peña J, Molina IJ. Defective actin reorganization and polymerization of Wiskott-Aldrich T cells in response to CD3-mediated stimulation. Blood 1997; 90: 3089-97.
104. Prchal JT, Carroll AJ, Prchal JF et al. Wiskott-Aldrich syndrome: cellular impairments and their implication for carrier detection. Blood 1980; 56: 1048-54.
105. Puck J, Krauss C, Puck S, Buckley R, Conley M. Prenatal test for X-linked severe combined immunodeficiency by analysis of maternal X-chromosome inactivation and linkage analysis. N Engl J Med 1990; 322: 1063-6.
106. Wengler G, Gorlin JB, Williamson JM, Rosen FS, Bing DH. Nonrandom inactivation of the X chromosome in early lineage hematopoietic cells in carriers of Wiskott-Aldrich syndrome. Blood 1995; 85: 2471-7.
107. Mullen CA, Anderson KD, Blaese RM. Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases. Blood 1993; 82: 2961-6.
108. Filipovich AH, Shapiro RS, Ramsay NK et al. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. Blood 1992; 80: 270-6.
109. Kvittingen EA, Rootwelt H, Brandtzaeg P, Bergan A, Berger R. Hereditary tyrosinemia type I. Selfinduced correction of the fumarylacetoacetase defect. J Clin Invest 1993; 91: 1816-21.
110. Hirschhorn R, Yang DR, Puck JM, Huie ML, Jiang CK, Kurlandsky LE. Spontaneous in vivo reversion to normal of an inherited mutation in a patient with adenosine deaminase deficiency. Nat Genet 1996; 13: 290-6.
111. D'Andrea AD, Grompe M. Molecular biology of Fanconi anemia: implications for diagnosis and therapy. Blood 1997; 90: 1725-36.
112. Ellis NA, Lennon DJ, Proytcheva M, Aldadeff B, Henderson EE, German J. Somatic intragenic recombination within the mutated locus BLM can correct the high sister-chromatid exchange phenotype of Bloom syndrome cells. Am J Hum Genet 1995; 57: 1019-27.
113. Frattini A, Blair HC, Sacco MG et al. Rescue of ATPa3-deficient murine malignant osteopetrosis by hematopoietic stem cell transplantation in utero. Proc Natl Acad Sci U S A 2005; 102: 14629-34.
114. Liechty KW, MacKenzie TC, Shaaban AF et al. Human mesenchymal stem cells engraft and demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med 2000; 6: 1282-6.
115. Dominici M, Pritchard C, Garlits JE, Hofmann TJ, Persons DA, Horwitz EM. Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation. Proc Natl Acad Sci U S A 2004; 101: 11761-6.
116. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation. A status report. JAMA 1997; 278: 932-7.
117. Jones DR, Bui TH, Anderson EM et al. In utero haematopoietic stem cell transplantation: current perspectives and future potential. Bone Marrow Transplant 1996; 18: 831-37.
118. Westgren M. In utero stem cell transplantation. Semin Reprod Med 2006; 24: 348-57.
119. Hayward A, Ambruso D, Battaglia F et al. Microchimerism and tolerance following intrauterine transplantation and transfusion for a-thalassemia-1. Fetal Diagn Ther 1998; 13: 8-14.
120. Westgren M, Ringden O, Bartmann P et al. Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodefi- ciency. Am J Obstet Gynecol 2002; 187: 475-82.
121. Westgren M, Ringden O, Sturla E-N et al. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation 1996; 61: 1176-9.
122. Flake AW, Zanjani ED. Treatment of severe combined immunodeficiency [Letter to the Editor]. N Engl J Med 1999; 341: 291.
123. Bartolome J, Porta F, Lafranchi A et al. B cell function after haploidentical in utero bone marrow transplantation in a patient with severe combined immunodeficiency. Bone Marrow Transplant 2002; 29: 625-8.
124. Le Blanc K, Gotherstrom C, Ringden O et al. Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta. Transplantation 2005; 79: 1607-14.